Asia Africa Streptokinase Trial "AASIST"

Not yet recruiting

Phase 2 Results N/A

Summary of Purpose

Currently, thrombolysis is offered to less than 1% of patients in low to middle income countries (LMICs) where access to health care is often based on the financial capabilities of the patient. There is therefore an urgent need for an effective but affordable alternative thrombolytic agent. Streptokinase (SK) ($35) is much more economically feasible as opposed to tissue plasminogen activator (tPA) ($2800). In...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 December 2014.

1 Jun 2014 20 May 2014 1 Jun 2016 1 Sep 2016 1 Dec 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


  • Ashfaq Shuaib, MD FRCPC